Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Developments in cytogenetics and oncogenes in acute leukemia

M P Strout1, M A Caligiuri

  • 1Rosewell Park Cancer Institute, Division of Medicine, Buffalo, NY 14263, USA.

Current Opinion in Oncology
|January 1, 1997
PubMed
Summary

Cancer is a genetic disorder, particularly evident in acute leukemia. Recent cytogenetic and molecular biology advances reveal oncogenes and leukemogenesis mechanisms, offering insights into normal cell function.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeting FLT3 by chimeric antigen receptor T cells for the treatment of acute myeloid leukemia.

Leukemia·2017
Same author

E3 ubiquitin ligase Cbl-b activates the p53 pathway by targeting Siva1, a negative regulator of ARF, in FLT3 inhibitor-resistant acute myeloid leukemia.

Leukemia·2016
Same author

The dual epigenetic role of PRMT5 in acute myeloid leukemia: gene activation and repression via histone arginine methylation.

Leukemia·2015
Same author

Receptor tyrosine kinase Axl is required for resistance of leukemic cells to FLT3-targeted therapy in acute myeloid leukemia.

Leukemia·2015
Same author

Somatic mutational landscape of AML with inv(16) or t(8;21) identifies patterns of clonal evolution in relapse leukemia.

Leukemia·2015
Same author

Targeting leukemia stem cells in vivo with antagomiR-126 nanoparticles in acute myeloid leukemia.

Leukemia·2015

Area of Science:

  • Genetics
  • Molecular Biology
  • Oncology

Background:

  • Cancer is increasingly understood as a genetic disorder.
  • Cytogenetic and molecular biology advancements are key to this understanding.
  • Acute leukemia serves as a prime example of genetic links to cancer.

Purpose of the Study:

  • To review recent advances in cancer genetics.
  • To highlight the role of cytogenetics in acute leukemia research.
  • To discuss novel mechanisms of leukemogenesis.

Main Methods:

  • Review of recent literature in cytogenetics and molecular biology.
  • Analysis of nonrandom cytogenetic abnormalities in acute leukemia.
  • Characterization of oncogenes and their products.

Related Experiment Videos

Main Results:

  • Identification of specific nonrandom cytogenetic abnormalities in acute leukemia.
  • Discovery and characterization of associated oncogenes.
  • Elucidation of novel mechanisms driving leukemogenesis.

Conclusions:

  • Cancer's genetic basis is firmly established, especially in acute leukemia.
  • Understanding oncogenes and leukemogenesis mechanisms provides insights into normal cell function.
  • Ongoing research continues to advance the field of cancer genetics.